<VariationArchive RecordType="classified" VariationID="21266" VariationName="NM_015922.3(NSDHL):c.1098dup (p.Arg367fs)" VariationType="Duplication" Accession="VCV000021266" Version="7" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2023-09-03" DateCreated="2013-04-04" MostRecentSubmission="2022-12-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="34118" VariationID="21266">
      <GeneList>
        <Gene Symbol="NSDHL" FullName="NAD(P) dependent steroid dehydrogenase-like" GeneID="50814" HGNC_ID="HGNC:13398" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="152831063" stop="152869729" display_start="152831063" display_stop="152869729" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NW_025791818.1" start="446253" stop="484919" display_start="446253" display_stop="484919" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="151999510" stop="152037906" display_start="151999510" display_stop="152037906" Strand="+" />
          </Location>
          <OMIM>300275</OMIM>
          <Haploinsufficiency last_evaluated="2019-09-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NSDHL">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-09-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NSDHL">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_015922.3(NSDHL):c.1098dup (p.Arg367fs)</Name>
      <CanonicalSPDI>NC_000023.11:152869089:TTT:TTTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="152869089" stop="152869090" display_start="152869089" display_stop="152869090" variantLength="1" positionVCF="152869089" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="152037633" stop="152037634" display_start="152037633" display_stop="152037634" variantLength="1" positionVCF="152037633" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
      </Location>
      <ProteinChange>R367fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001129765.2" sequenceAccession="NM_001129765" sequenceVersion="2" change="c.1098dupT">
            <Expression>NM_001129765.2:c.1098dupT</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001129765.1" sequenceAccession="NM_001129765" sequenceVersion="1" change="c.1098dupT">
            <Expression>NM_001129765.1:c.1098dupT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.152037636dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.152037636dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.152869092dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.152869092dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009163.2" sequenceAccession="NG_009163" sequenceVersion="2" change="g.43126dup">
            <Expression>NG_009163.2:g.43126dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001129765.2" sequenceAccession="NM_001129765" sequenceVersion="2" change="c.1098dup">
            <Expression>NM_001129765.2:c.1098dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001123237.1" sequenceAccession="NP_001123237" sequenceVersion="1" change="p.Arg367fs">
            <Expression>NP_001123237.1:p.Arg367fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015922.3" sequenceAccession="NM_015922" sequenceVersion="3" change="c.1098dup" MANESelect="true">
            <Expression>NM_015922.3:c.1098dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_057006.1" sequenceAccession="NP_057006" sequenceVersion="1" change="p.Arg367fs">
            <Expression>NP_057006.1:p.Arg367fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA341816" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="300275.0007" DB="OMIM" />
        <XRef Type="rs" ID="121909834" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_015922.3(NSDHL):c.1098dup (p.Arg367fs) AND CK syndrome" Accession="RCV000020428" Version="16">
        <ClassifiedConditionList TraitSetID="6280">
          <ClassifiedCondition DB="MedGen" ID="C3151781">CK syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-12-14" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-12-14" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2013-04-04" MostRecentSubmission="2022-12-17">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19377476</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21129721</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">21290788</ID>
          <ID Source="BookShelf">NBK51754</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6280" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15758" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICAL MALFORMATION</ElementValue>
                <XRef Type="MIM" ID="300831" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">NSDHL-Related Disorders</ElementValue>
                <XRef ID="NSDHL-Related+Disorders/9023" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">CK syndrome</ElementValue>
                <XRef ID="MONDO:0010441" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The NSDHL-related disorders include: CHILD (congenital hemidysplasia with ichthyosiform nevus and limb defects) syndrome, an X-linked condition that is usually male lethal during gestation and thus predominantly affects females; and CK syndrome, an X-linked disorder that affects males. CHILD syndrome is characterized by unilateral distribution of ichthyosiform (yellow scaly) skin lesions and ipsilateral limb defects that range from shortening of the metacarpals and phalanges to absence of the entire limb. Intellect is usually normal. The ichthyosiform skin lesions are usually present at birth or in the first weeks of life; new lesions can develop in later life. Nail changes are also common. The heart, lung, and kidneys can also be involved. CK syndrome (named for the initials of the original proband) is characterized by mild to severe cognitive impairment and behavior problems (aggression, attention deficit hyperactivity disorder, and irritability). All affected males reported have developed seizures in infancy and have cerebral cortical malformations and microcephaly. All have distinctive facial features, a thin habitus, and relatively long, thin fingers and toes. Some have scoliosis and kyphosis. Strabismus is common. Optic atrophy is also reported.</Attribute>
                <XRef ID="NBK51754" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">21290788</ID>
                <ID Source="BookShelf">NBK51754</ID>
              </Citation>
              <XRef ID="251383" DB="Orphanet" />
              <XRef ID="C3151781" DB="MedGen" />
              <XRef ID="MONDO:0010441" DB="MONDO" />
              <XRef Type="MIM" ID="300831" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="49393" SubmissionDate="2012-05-04" DateLastUpdated="2022-09-17" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300275.0007_CK SYNDROME" title="NSDHL, 1-BP DUP, 1098T_CK SYNDROME" />
        <ClinVarAccession Accession="SCV000044137" DateUpdated="2022-09-17" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2010-12-10">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of a 3-generation family with CK syndrome (300831), Tarpey et al. (2009) and McLarren et al. (2010) identified a hemizygous 1-bp duplication (1098dupT) in the NDSHL gene, resulting in an arg367-to-ser (R367S) substitution, frameshift, and extension of the protein past the native stop codon and into the 3-prime untranslated region. The mutation was not identified in 224 controls. By studies in patient cells, HEK293 cells, and yeast cells, McLarren et al. (2010) showed that the mutant protein was temperature-sensitive: at 30 degrees Celsius, the protein was expressed, folded, localized, and functioned correctly, but at 37 degrees, the protein was improperly folded and degraded, resulting in a loss of function. Affected males and obligate female carriers had normal plasma cholesterol, steroid hormone levels, and lipoprotein profiles, but cultured lymphoblastoid cells expressing the mutation showed sterol aberrations, such as accumulation of 4-methyl sterol intermediates, 4,4-dimethyl sterol intermediates, lathosterol, and desmosterol. Cerebrospinal fluid from an affected individual also showed increased methylsterol levels. McLarren et al. (2010) suggested that the phenotype resulted mainly from the accumulation of toxic methylsterols, not necessarily from cholesterol deficiency.</Attribute>
              <Citation>
                <ID Source="PubMed">19377476</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">21129721</ID>
              </Citation>
              <XRef DB="OMIM" ID="300831" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NSDHL" />
          </GeneList>
          <Name>NSDHL, 1-BP DUP, 1098T</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 1098T</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300275.0007" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CK SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="40832" SubmissionDate="2023-08-21" DateLastUpdated="2022-10-01" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="NM_001129765.1:c.1098dupT|OMIM:300831" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV000040832" DateUpdated="2022-10-01" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="Bookshelf">NBK51754</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001129765.1:c.1098dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="300831" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13777577</SubmissionName>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5002881" SubmissionDate="2022-12-11" DateLastUpdated="2022-12-17" DateCreated="2022-08-08">
        <ClinVarSubmissionID localKey="sa_pathology/molecular_pathology_fmc/vc23267" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002556927" DateUpdated="2022-12-17" DateCreated="2022-08-08" Type="SCV" Version="2" SubmitterName="Genetics and Molecular Pathology, SA Pathology" OrgID="506043" OrganizationCategory="laboratory" OrgAbbreviation="GMP-FMC" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NSDHL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_12291</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001129765.2:c.1098dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="300831" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_36</SubmissionName>
          <SubmissionName>submission_33</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="49393" TraitType="Disease" MappingType="Name" MappingValue="CK SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C3151781" Name="CK syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5002881" TraitType="Disease" MappingType="XRef" MappingValue="300831" MappingRef="OMIM">
        <MedGen CUI="C3151781" Name="CK syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="40832" TraitType="Disease" MappingType="XRef" MappingValue="300831" MappingRef="OMIM">
        <MedGen CUI="C3151781" Name="CK syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

